Metoprolol Succinate
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Actavis Pharma, Inc. | generic | 6 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Metoprolol Succinate Tablet, Extended Release — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Cardiovascular.
Metoprolol Succinate Tablet, Extended Release — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Cardiovascular.
Failed Dissolution Specifications — Recalling firm: Teva Pharmaceuticals USA, Inc — Nationwide
Failed Dissolution Specifications — Recalling firm: Teva Pharmaceuticals USA, Inc — Nationwide
Failed Dissolution Specifications — Recalling firm: Teva Pharmaceuticals USA, Inc — Nationwide
Failed Dissolution Specifications — Recalling firm: Teva Pharmaceuticals USA, Inc — Nationwide
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. — Recalling firm: CARDINAL HEALTHCARE — Nationwide USA
